Jens Kringelum

Company: Evaxion Biotech

Job title: Vice President, AI & Innovation

Seminars:

Spotlighting New Sources for Personalized Neoantigen Treatment 3:30 pm

Overcoming the difficulties found in patients with low number of mutations by exploring  novel personalized cancer treatments that aren’t solely targeting neoepitopes arising from missense mutations Discovering new sources of targetable epitopes to develop personalized cancer vaccines in patient populations with low mutational burden (low-TMB) Exploring genomic rearrangement, splice variants and ERVs as potential new sources to be…Read more

day: Day One